New to The Street’s TV Host Jane King and Co-Host David T. Fagan, President of Top Talent Agency, interview Dr. Ari Soffer, MD, Founder and CEO of SimpleMD®. From the Nasdaq MarketSite studio, Dr. Soffer talks about the class of drugs in the marketplace that treat obesity issues. Ozempic and Wegovy are drugs with a 20-year track record in treating those with diabetes. A secondary result became apparent when treating people with diabetes with these drugs – weight loss. Medical professionals are now using these drugs to help those with weight issues. Novo Nordisk, which makes Ozempic, is now one of the largest companies in Europe due to the demand for the drug for weight management treatments and solutions. Dr. Soffer explains that diets fail people, not people failing because of a diet. Scientific evidence shows that weight issues are biological and need a biological treatment. Ozempic and similar drugs are safe solutions for obtaining optimal weight. SimpleMD® can assist those looking for a comprehensive weight management program and platform under the supervision of highly trained medical professionals. The on-screen QR code is available during the shows; download or visit Simple MD – https://simplemd.com/.
To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/c/newtothestreettv
Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/
Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list